Home / Single Stock Portfolios / Global Healthcare

Global Healthcare

Healthcare is a universal and permanent human need, which makes it an excellent defensive equity exposure.

Strategy Description

Healthcare is a universal and permanent human need, which makes it an excellent defensive equity exposure.

Moving beyond traditional pharmaceutical companies, the Global Healthcare portfolio also invests in healthcare & bio technology firms, healthcare providers and equipment manufacturers.

The portfolio seeks to strike a balance between large companies and small, famous brand names and reasonably valued ones, promising ideas and sustainable businesses.

We score stocks on Value, Quality, Safety, Payout, Technical and Sentiment metrics, as well as ESG traits, to ensure lesser-known but still excellent companies are included.

Lastly, we aim to diversify by region and sector where possible to ensure themes are captured holistically and globally.

PrintFact Sheet

Portfolio Performance

2020202120222023YTD
Portfolio (%)9.2414.61-7.543.935.12
Annualized ReturnStandard DeviationDividend Yield
Portfolio4.77%15.24%3.1%

Allocation Breakdown

Asset Class


Equity99.55%
Fixed Income0
Commodities0
Cash0.45%

Geo


North America51.23%
Greater Europe35.48%
Asia12.86%
Central/Latin America0

Sector


Biotechnology10.9%
Health Care Equipment12.05%
Healthcare Facilities7.25%
Health Care Services11.17%
Pharmaceuticals58.19%

Top Holdings

Asset ClassWeight (%)
1. UCB SA8.21%
2. HCA Healthcare Inc7.28%
3. Merck & Co Inc6.29%
4. AbbVie Inc6.28%
5. Medtronic PLC6.13%
6. GSK PLC5.98%
7. Abbott Laboratories5.94%
8. Cigna Group/The5.88%
9. Laboratory Corp of America Holdings5.38%
10. Sanofi SA5.38%